Hindustan Unilever Ltd (NSE: HINDUNILVR) — Comprehensive Equity Research Report

Published: June 2026 | Sector: FMCG | Market Cap: ₹4,88,010 Cr | CMP: ₹2,077

Executive Summary

Hindustan Unilever Ltd (HUL) is India's largest fast-moving consumer goods (FMCG) company, with a heritage spanning over 90 years in the Indian market. A subsidiary of Unilever PLC (which holds approximately 61.90% stake), HUL commands a market capitalization of ₹4,88,010 crore, making it one of the most valuable companies listed on Indian exchanges. The stock currently trades at ₹2,077 per share, down 0.39% on the day of analysis, with a 52-week high of ₹2,660 and a 52-week low of ₹2,022.

For FY2026, HUL reported consolidated revenue of ₹64,468 crore and net profit of ₹15,059 crore, translating to an EPS of ₹64.01. The company maintains a stellar return on capital employed (ROCE) of 28.4% and return on equity (ROE) of 22.3%, underscoring its capital efficiency. With a dividend yield of 1.98% and a payout ratio of 64% in FY2026, HUL continues to reward shareholders generously. The stock trades at a P/E of 44.7x, reflecting its premium positioning in the FMCG sector.

This report provides a deep dive into HUL's financial performance, business segments, peer comparison, shareholding trends, valuation metrics, and the road ahead for India's FMCG bellwether.

Company Overview

Hindustan Unilever operates across three primary business segments: Home Care, Beauty & Personal Care, and Foods & Refreshments. The company boasts a portfolio of over 50 brands spanning 16 FMCG categories, including 19 brands with an annual turnover exceeding ₹1,000 crore each.

Iconic Brand Portfolio

HUL's brand arsenal reads like a who's who of Indian household names:

• Home Care: Surf Excel, Rin, Vim, Domex, Wheel
• Beauty & Personal Care: Lux, Lifebuoy, Dove, Fair & Lovely (now Glow & Lovely), Clinic Plus, Sunsilk, Pepsodent, Closeup
• Foods & Refreshments: Bru, Brooke Bond, Kissan, Kwality Wall's, Knorr

The company reaches approximately 8 million outlets across India, with an extensive distribution network that penetrates both urban and rural markets. Through its Project Shakti initiative, HUL has built a rural reach via thousands of micro-entrepreneurs, making it one of the most deeply penetrated FMCG companies in the country.

Financial Performance — FY2026 Results

Revenue Performance

HUL reported consolidated sales of ₹64,468 crore for FY2026, representing a modest growth of 2.1% over FY2025's ₹63,121 crore. The revenue trajectory over the past decade shows a consistent upward trend:

The 10-year compounded sales growth stands at 7%, while the 5-year CAGR is also 7%. The 3-year and TTM growth rates are more modest at 2% each, reflecting the challenging demand environment in recent years.

Profitability Analysis

The operating profit for FY2026 was ₹15,039 crore with an operating profit margin (OPM) of 23%. This represents a slight compression from the peak OPM of 25% achieved in FY2020–FY2022, but remains healthy by industry standards.

Net profit for FY2026 surged to ₹15,059 crore, a significant jump from ₹10,671 crore in FY2025. However, this includes an exceptionally high other income of ₹4,923 crore (compared to ₹1,322 crore in FY2025), which inflated the bottom line. The effective tax rate dropped to 17% in FY2026 from 26% in FY2025, further boosting net profit.

Stripping out the other income anomaly, the underlying profit growth trajectory is more moderate. The 10-year profit CAGR is 10%, while the 5-year CAGR is 6% and 3-year CAGR is 2%. The TTM profit growth is 5%.

Quarterly Performance (Q4 FY2026)

For the quarter ended March 2026, HUL reported:

• Sales: ₹16,351 crore (up 7.6% YoY)
• Operating Profit: ₹3,837 crore (OPM: 23%)
• Net Profit: ₹2,994 crore (up 8.6% YoY)
• EPS: ₹12.73

The quarterly revenue of ₹16,351 crore was the highest in recent quarters, indicating improving demand conditions. The sequential trend shows stability: Q1 FY2026 at ₹16,514 crore, Q2 at ₹15,919 crore, Q3 at ₹16,441 crore, and Q4 at ₹16,351 crore.

Expense Breakdown

Total expenses for FY2026 stood at ₹49,429 crore, representing 76.7% of sales. Key expense items include:

• Depreciation: ₹1,333 crore (up from ₹1,355 crore in FY2025)
• Interest: ₹410 crore (up from ₹395 crore in FY2025)
• Tax: Effective rate of 17% (down from 26%)

The cost structure has been well-managed, with raw material and other operating expenses forming the bulk of the expenditure.

Balance Sheet Strength

HUL maintains a robust balance sheet with total assets of ₹79,752 crore as of March 2026.

Asset Composition

Liability Structure

The company is virtually debt-free with borrowings of just ₹1,478 crore against a net worth of approximately ₹48,739 crore. The debt-to-equity ratio is negligible at approximately 0.03x, which is a significant strength. Book value per share stands at ₹207, and the stock trades at 9.99x book value.

Cash Flow Analysis

HUL is a strong free cash flow generator, a hallmark of quality FMCG businesses.

Key observations:

• Cash from operations in FY2026 was ₹10,999 crore, maintaining the ₹10,000+ crore level for the third consecutive year
• Free cash flow of ₹9,668 crore in FY2026 demonstrates continued cash generation prowess
• The CFO-to-operating-profit ratio averaged approximately 100% over the past decade, indicating high-quality earnings with minimal accrual distortions
• Investing outflows of ₹3,684 crore in FY2026 reflect continued capex commitment
• Financing outflows of ₹10,810 crore primarily reflect dividends and buybacks

The cumulative free cash flow over the past 5 years (FY2022–FY2026) totals approximately ₹51,279 crore, demonstrating HUL's exceptional ability to convert profits into cash.

Working Capital Efficiency

HUL demonstrates best-in-class working capital management with a negative cash conversion cycle, meaning it collects from customers faster than it pays suppliers.

The negative cash conversion cycle of -79 days in FY2026 is a remarkable feat, meaning HUL effectively operates with supplier-funded working capital. This is a hallmark of strong FMCG businesses with pricing power and distribution dominance.

Key Financial Ratios

The ROCE has been consistently above 25% in recent years (FY2026: 28.4%), while the 10-year average ROE of 27% is exceptionally high. However, the reported ROCE figures were much higher pre-IFRS (FY2015: 139%, FY2016: 112%), reflecting changes in accounting standards and balance sheet structure after the merger with GSK Consumer Healthcare in 2020.

Dividend History

HUL is known for its generous dividend payouts, maintaining a dividend payout ratio averaging 87% over the past decade.

The company has been maintaining a healthy dividend payout of 92.4% on average, as noted by Screener.in. The payout exceeded 100% in FY2021 (119%) and FY2025 (117%), where dividends exceeded net profit, funded by accumulated reserves. The FY2026 payout of 64% is lower, possibly due to the inflated profit from exceptional other income.

With a current dividend yield of 1.98% at CMP of ₹2,077, HUL remains attractive for income-seeking investors, especially given its track record of consistent payouts.

Shareholding Pattern Analysis

Current Shareholding (Q4 FY2026 — March 2026)

Key Shareholding Trends

Promoter Holding: Unchanged at 61.90% since FY2021, when it was reduced from 67.18% (likely through the GSK Consumer Healthcare merger-related adjustment). The stability of promoter holding signals long-term commitment.

FII Decline: Foreign Institutional Investors have been consistently reducing their stake:

• Mar 2022: 13.66%
• Mar 2023: 14.36%
• Mar 2024: 12.67%
• Mar 2025: 10.62%
• Mar 2026: 10.10%

The FII holding has dropped from 14.95% in FY2021 to 10.10% in FY2026, a decline of nearly 5 percentage points. This sustained FII selling has been a key overhang on the stock price.

DII Increase: Domestic Institutional Investors have steadily increased their stake from 5.66% in FY2017 to 16.33% in FY2026, reflecting growing domestic institutional confidence. Mutual funds and insurance companies have been absorbing the FII selling.

Shareholder Count: The number of shareholders stood at 11,06,831 in March 2026, down from a peak of 13,61,506 in March 2022, suggesting some retail consolidation.

Peer Comparison

HUL operates in the Diversified FMCG segment alongside peers like ITC, Hindustan Foods, and others.

Key Takeaways from Peer Comparison:

• HUL trades at a significant premium to ITC (44.7x vs 16.8x P/E), reflecting its pure-play FMCG positioning versus ITC's diversified conglomerate structure
• ITC offers a superior dividend yield of 5.20% versus HUL's 1.98%
• HUL's ROCE of 28.42% is strong but trails ITC's 38.93%
• HUL's quarterly profit growth of 8.62% is better than ITC's 5.30%, while quarterly sales growth of 7.64% also outpaces ITC's -5.01% decline
• Hindustan Foods shows faster growth metrics but at a much smaller scale

Earnings Per Share (EPS) Trajectory

The EPS growth has been a mixed story:

The FY2026 EPS of ₹64.01 represents a 41.2% jump, but this is heavily influenced by the exceptional other income of ₹4,923 crore and a lower effective tax rate of 17%. Normalizing for these items, the underlying EPS growth would be in the mid-single digits, consistent with the revenue growth trajectory.

Stock Price Performance

The stock has significantly underperformed over recent timeframes:

The stock is currently trading at ₹2,077, which is approximately 22% below its 52-week high of ₹2,660 and only 2.7% above its 52-week low of ₹2,022. This underperformance is attributable to:

1. Elevated valuations that were unsustainable at 60–70x P/E during the pandemic period
2. FII selling pressure with holdings declining from ~15% to ~10%
3. Slowing revenue growth in the 2% range over the past 3 years
4. Rural demand weakness impacting volume growth
5. Input cost inflation compressing margins from the 25% peak

Strengths and Weaknesses

Strengths

1. Debt-free balance sheet with borrowings of just ₹1,478 crore against a net worth of ~₹48,739 crore
2. Exceptional dividend payout averaging 92.4%, providing consistent income
3. Portfolio of iconic brands with strong consumer recall and pricing power
4. Pan-India distribution reaching ~8 million outlets
5. Negative working capital cycle (-79 days), indicating supplier-funded operations
6. Consistent ROCE of ~28% demonstrating capital efficiency
7. Strong free cash flow generation of ₹9,668 crore in FY2026
8. Parentage of Unilever PLC providing access to global R&D and best practices

Weaknesses

1. Trading at 9.99x book value, indicating expensive valuations relative to asset base
2. Poor sales growth of 6.51% CAGR over the past five years
3. Other income of ₹4,923 crore inflating reported earnings
4. FII exodus with holdings declining steadily over 5 years
5. Volume growth challenges in a competitive market
6. Premium valuation (44.7x P/E) limits upside potential

Valuation Analysis

Current Valuation Metrics

• P/E Ratio: 44.7x (on trailing FY2026 EPS of ₹64.01)
• Normalized P/E: ~55–60x (adjusting for exceptional other income and low tax rate)
• Price-to-Book: 9.99x
• EV/EBITDA: ~30x (estimated)
• Dividend Yield: 1.98%

Historical Valuation Range

HUL has historically traded at a premium P/E range of 40–70x. The current P/E of 44.7x is at the lower end of this range, suggesting relatively better value compared to historical norms. However, when normalized for the exceptional other income, the effective P/E is higher at 55–60x.

Fair Value Estimates

• Based on 45x normalized EPS of ₹48–50: Fair value of ₹2,160–₹2,250
• Based on DCF with 10% discount rate and 8% long-term growth: Fair value of approximately ₹2,300–₹2,500
• Based on sector median P/E of ~35x: Target of ₹2,240 on normalized EPS

The stock appears fairly valued at current levels, with limited margin of safety for new investors but reasonable for long-term holders given the quality of the franchise.

Growth Drivers and Catalysts

Near-Term Catalysts

1. Rural demand recovery: Government spending and good monsoons could revive rural consumption, which forms a significant portion of HUL's revenue
2. Premiumization trend: Shifting consumer preferences toward premium products across categories
3. Price-mix improvement: Strategic price increases and portfolio mix optimization
4. Margin recovery: Easing input costs (palm oil, crude derivatives) could expand margins
5. Distribution expansion: Continued deepening of direct distribution reach

Long-Term Growth Drivers

1. India's consumption story: Per capita FMCG spending in India is among the lowest globally, offering massive headroom
2. Urbanization: Rising urban population drives premium product adoption
3. Digital and e-commerce: Growing online sales channels opening new growth avenues
4. New product launches: Leveraging global Unilever R&D for India-specific innovations
5. Market share gains: HUL continues to win market share in ~80% of its portfolio

Risk Factors

1. Intensifying competition from D2C brands, regional players, and multinational competitors
2. Input cost volatility — palm oil, crude oil derivatives, and packaging materials
3. Regulatory risks including advertising restrictions and product reformulation requirements
4. Slowdown in consumer spending due to macroeconomic headwinds
5. Currency risk on imported raw materials
6. Parent company decisions — Unilever's global strategy changes could impact HUL
7. Valuation risk — premium multiples leave little room for disappointment

Investment Thesis

For Long-Term Investors

HUL represents a compounding machine with an unmatched brand portfolio, distribution reach, and balance sheet strength. The company's ability to generate ₹10,000+ crore in free cash flow annually, maintain ~28% ROCE, and pay out ~90% of profits as dividends makes it a cornerstone holding for any Indian equity portfolio.

However, investors should temper return expectations. With revenue growth normalizing to 2–3% and the stock trading at 44.7x earnings, total returns are likely to be driven primarily by dividends (~2%) and modest earnings growth (~6–8%), yielding a potential 8–10% annual return over the next 3–5 years.

For Value Investors

The stock is not cheap by any metric. At 9.99x book value and 44.7x earnings, HUL is priced for perfection. Value investors may find better opportunities in other FMCG names like ITC (16.8x P/E, 5.2% dividend yield) or in beaten-down mid-cap FMCG stocks.

For Income Investors

With a 1.98% dividend yield and a track record of 92.4% payout ratio, HUL is a reliable income generator. The yield is modest but backed by an exceptionally strong balance sheet and cash flows.

Conclusion

Hindustan Unilever remains the gold standard of Indian FMCG investing. Its portfolio of 50+ brands, distribution across 8 million outlets, near-zero debt, and consistent 28%+ ROCE make it a quality compounder. The FY2026 results showed revenue of ₹64,468 crore and net profit of ₹15,059 crore, though the latter was inflated by ₹4,923 crore in other income.

The key challenge for HUL is the growth moderation — with revenue growing at just 2% over the past three years and the stock delivering -7% CAGR over 3 years. The FII exodus (from 14.95% to 10.10% over 5 years) has been absorbed by DIIs (from 10.68% to 16.33%), but this transition creates near-term price volatility.

For investors, HUL is best approached as a long-term compounder rather than a momentum play. At current levels of ₹2,077, the stock offers a reasonable entry point for patient investors who understand they are buying quality at a fair (not cheap) price. The 1.98% dividend yield provides a floor, while any improvement in volume growth or margin expansion could catalyze a meaningful re-rating.

Verdict: HOLD for existing investors; ACCUMULATE on dips for long-term portfolios with a 3–5 year horizon.

Detailed Quarterly Trend Analysis (FY2023–FY2026)

A granular look at quarterly performance reveals the underlying momentum and volatility in HUL's business:

Revenue Trend (₹ Crore)

The revenue trajectory shows a clear acceleration in FY2026, with Q1 and Q3 showing strong growth of +8.7% and +3.3% QoQ respectively. The YoY growth in Q4 FY2026 of 7.6% is the strongest quarterly comparison in several years, signaling a potential inflection point.

Operating Profit Trend (₹ Crore)

Operating margins have remained remarkably stable in the 23–24% band for 13 consecutive quarters, demonstrating HUL's ability to manage cost pressures through pricing actions and operational efficiency. The absolute operating profit has shown a gradual upward trend, reaching ₹3,837 crore in Q4 FY2026 — the highest quarterly figure in the dataset.

Net Profit Trend (₹ Crore)

The Q3 FY2026 net profit of ₹6,603 crore (EPS: ₹28.12) is a clear outlier, driven by exceptional other income of ₹4,048 crore and a remarkably low tax rate of 11%. Stripping out this anomaly, the underlying quarterly net profit trend is in the ₹2,500–₹3,000 crore range, with Q4 FY2026's ₹2,994 crore representing solid performance.

Business Segment Deep Dive

Home Care Segment

Home Care is one of HUL's largest segments, encompassing fabric wash (Surf Excel, Rin, Wheel), household care (Vim, Domex), and related products. This segment benefits from:

• Daily consumption nature ensuring consistent demand
• Wide price architecture from mass-market (Wheel) to premium (Surf Excel)
• Strong brand equity built over decades
• Market leadership in most sub-categories

The segment has been a key beneficiary of the premiumization trend, with consumers trading up from mass to premium variants. However, it faces competition from regional brands and private labels.

Beauty & Personal Care Segment

This segment includes skin care (Fair & Lovely/Glow & Lovely), hair care (Clinic Plus, Sunsilk, Dove), personal wash (Lux, Lifebuoy), and oral care (Pepsodent, Closeup). Key dynamics include:

• High margin profile relative to other segments
• Strong brand portfolio spanning multiple price points
• Growing premium and naturals segment offering growth opportunities
• E-commerce channel growth particularly for premium brands

The segment has faced challenges from D2C brands and natural/ayurvedic alternatives, but HUL's scale and distribution advantages provide a strong competitive moat.

Foods & Refreshments Segment

Following the merger with GSK Consumer Healthcare in 2020, HUL gained control of Horlicks and Boost, significantly expanding its foods portfolio. The segment now includes:

• Tea/Coffee: Brooke Bond, Bru
• Foods: Kissan, Knorr
• Ice Cream: Kwality Wall's
• Health Drinks: Horlicks, Boost

The integration of GSK brands has been largely completed, though the segment continues to face commodity cost pressures (tea, milk, sugar) and competitive intensity from both established players and new entrants.

Historical Context and Strategic Milestones

GSK Consumer Healthcare Merger (2020)

The ₹31,700 crore merger of GSK Consumer Healthcare India with HUL in 2020 was a transformative event, adding brands like Horlicks, Boost, and Viva to HUL's portfolio. This merger:

• Expanded HUL's addressable market significantly
• Added ₹6,000–7,000 crore in annual revenue
• Strengthened the foods and refreshments segment
• Led to a change in promoter holding from 67.18% to 61.90%

The integration involved revaluation of assets, which explains the sharp jump in fixed assets from ₹5,479 crore in FY2020 to ₹51,443 crore in FY2021.

Simplification of Structure

In 2020–2021, HUL undertook a simplification exercise, merging several wholly-owned subsidiaries into the parent company. This reduced complexity and improved operational efficiency.

Sustainability Initiatives

HUL has been a pioneer in sustainability among Indian FMCG companies:

• Plastic waste management — commitment to collect and process more plastic than it uses
• Water conservation — reducing water usage across manufacturing
• Carbon footprint reduction — targets for carbon neutrality
• Sustainable sourcing — responsible sourcing of palm oil and other raw materials
• Rural livelihood — Project Shakti empowering women entrepreneurs

Management Quality and Governance

HUL benefits from world-class corporate governance standards inherited from Unilever PLC. Key governance highlights include:

• Independent board with experienced directors
• Transparent financial reporting with detailed segment disclosures
• Consistent dividend policy reflecting shareholder-friendly approach
• Professional management with deep FMCG expertise
• ESG leadership among Indian consumer companies

The company has a track record of prudent capital allocation, maintaining low leverage while investing in brands and distribution. The 92.4% average dividend payout over the past decade demonstrates commitment to returning cash to shareholders.

Sector Dynamics and Macro Context

Indian FMCG Market

India's FMCG market is estimated at $100+ billion and is expected to grow to $220 billion by 2030. Key sector trends include:

• Rural recovery after two years of weak demand
• Premiumization across categories
• Digital-first brands gaining traction
• Quick commerce (Blinkit, Zepto, Instamart) reshaping distribution
• Packaged foods penetration increasing post-COVID
• Health and wellness driving new product categories

Input Cost Environment

Key raw materials for HUL include:

• Palm oil and derivatives — major input for soaps and personal care
• Crude oil derivatives — packaging materials, synthetic chemicals
• Tea and coffee — beverages segment
• Milk and dairy — foods segment
• Fragrances and chemicals — personal care

The input cost environment has been moderating in FY2026, with palm oil prices stabilizing and crude oil remaining range-bound. This bodes well for margin expansion in coming quarters.

Competitive Landscape

HUL faces competition from multiple fronts:

• Multinational peers: P&G, Colgate-Palmolive, Nestle India, Reckitt Benckiser
• Indian conglomerates: ITC, Dabur, Marico, Godrej Consumer Products
• Regional players: strong in specific categories and geographies
• D2C brands: Mamaearth, WOW Skin Science, mCaffeine, and others
• Private labels: growing presence in modern trade and e-commerce

Despite intensifying competition, HUL's scale advantages, brand portfolio, and distribution depth remain formidable competitive moats that are difficult for competitors to replicate.

Technical Analysis Perspective

From a technical standpoint, the stock's price action suggests:

• Trading near 52-week lows (₹2,022 low vs. ₹2,077 current)
• Significant overhead resistance at ₹2,200–2,300 levels
• Support zone around ₹2,000–2,020
• RSI in oversold territory, potentially signaling a bounce
• Death cross (50 DMA below 200 DMA) indicating bearish medium-term trend

Investors with a long-term horizon may consider accumulating in the ₹1,950–2,100 range, while those with a medium-term perspective may wait for a trend reversal confirmation above ₹2,300.

Scenario Analysis

Bull Case (Target: ₹2,800–3,000)

• Revenue growth accelerates to 8–10% driven by volume recovery
• Operating margins expand to 25% with easing input costs
• FII selling abates, DII accumulation continues
• Market re-rates to 50x forward P/E
• Dividend yield at 2.2% with ₹45+ per share dividend

Base Case (Target: ₹2,200–2,500)

• Revenue growth of 4–6% with stable margins at 23–24%
• Normalized EPS of ₹48–52 in FY2027
• Market assigns 45x P/E for quality compounder
• Dividend yield of 2.0% provides income support

Bear Case (Target: ₹1,700–1,900)

• Revenue growth stagnates at 1–2%
• Margin compression to 21–22% from competitive pressures
• FII selling accelerates, market sentiment deteriorates
• P/E contracts to 38–40x
• Stock trades down to ₹1,700–1,900 range

Key Metrics Summary Table

Conclusion

Hindustan Unilever remains the gold standard of Indian FMCG investing. Its portfolio of 50+ brands, distribution across 8 million outlets, near-zero debt, and consistent 28%+ ROCE make it a quality compounder. The FY2026 results showed revenue of ₹64,468 crore and net profit of ₹15,059 crore, though the latter was inflated by ₹4,923 crore in other income.

The key challenge for HUL is the growth moderation — with revenue growing at just 2% over the past three years and the stock delivering -7% CAGR over 3 years. The FII exodus (from 14.95% to 10.10% over 5 years) has been absorbed by DIIs (from 10.68% to 16.33%), but this transition creates near-term price volatility.

For investors, HUL is best approached as a long-term compounder rather than a momentum play. At current levels of ₹2,077, the stock offers a reasonable entry point for patient investors who understand they are buying quality at a fair (not cheap) price. The 1.98% dividend yield provides a floor, while any improvement in volume growth or margin expansion could catalyze a meaningful re-rating.

Verdict: HOLD for existing investors; ACCUMULATE on dips for long-term portfolios with a 3–5 year horizon.